Watanabe, A.; Horigome, R.; Nakatsuka, Y.; Terai, S.
Correction: Watanabe et al. Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect. Livers 2023, 3, 562–568. Livers 2025, 5, 10.
https://doi.org/10.3390/livers5010010
AMA Style
Watanabe A, Horigome R, Nakatsuka Y, Terai S.
Correction: Watanabe et al. Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect. Livers 2023, 3, 562–568. Livers. 2025; 5(1):10.
https://doi.org/10.3390/livers5010010
Chicago/Turabian Style
Watanabe, Azuma, Ryoko Horigome, Yumiko Nakatsuka, and Shuji Terai.
2025. "Correction: Watanabe et al. Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect. Livers 2023, 3, 562–568" Livers 5, no. 1: 10.
https://doi.org/10.3390/livers5010010
APA Style
Watanabe, A., Horigome, R., Nakatsuka, Y., & Terai, S.
(2025). Correction: Watanabe et al. Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect. Livers 2023, 3, 562–568. Livers, 5(1), 10.
https://doi.org/10.3390/livers5010010